Merged into LumiraDx, ticker now LMDX
CAHC

Completed

LumiraDx

CA Healthcare Acquisition Corp.

Raised
$115M
CIK
1832352
Focus
Healthcare, Technology, Pharmaceuticals, Wellness
External link: SEC Filings

SPAC Team

Leadership

Larry J. Neiterman has served as chairman of our board of directors and our Chief Executive Officer since October 2020. From 2010 to May 2020, Mr. Neiterman was the Chief Operating Officer of the U.S. consulting practice of Deloitte Consulting LLP, a global consulting firm. From 1982 to 2009, he held various roles at Deloitte, focusing on strategic planning, mergers and merger integration, and operations consulting in the businesses of health insurance, healthcare providers and life sciences. Mr. Neiterman’s consulting work at Deloitte includes targeting and integrating significant acquisitions and joint ventures for clients. In his various leadership roles at Deloitte, he was a member of the executive team that completed acquisitions and joint ventures that enhanced the firm’s market position and had responsibility for the firm’s overall financial and operational performance. Mr. Neiterman graduated from Brown University with a BA in Economics and Organizational Behavior. He then earned his MBA in Finance and Strategic Planning from the Tuck School of Business at Dartmouth College. We believe Mr. Neiterman is well-qualified to serve as a member of our board of directors due to his experience as a business leader in a variety of industries and his contacts and relationships.

Jeffrey H. Barnes has served as a member of our board of directors and our President and Chief Financial Officer since October 2020. Since June 2019, Mr. Barnes runs a consultant practice, providing client with strategic guidance and market knowledge in the healthcare market. From April 2018 to May 2019, Mr. Barnes was Chief Executive Officer of Philips Canada, the Canadian subsidiary of Royal Philips, a global healthcare technology firm. From November 2014 to April 2018, Mr. Barnes was a Senior Vice President and North American Commercial Leader of Philips Healthcare. From August 2011 to November 2014, Mr. Barnes led Philips’s Home Healthcare business in North and South America. From May 2006 to August 2011, Mr. Barnes was an Executive Vice President of Global Commercial Operations for iCAD, a medical technology firm. Mr. Barnes is currently a board advisor for Luxsonic Technologies and was formerly a member of the board of directors at Philips Medical Capital and Virtual Incubation Companies. Mr. Barnes received his BA in Economics, cum laude, from St. Lawrence University and later earned his MBA from New York University’s Stern School of Business. We believe Mr. Barnes is well-qualified to serve as a member of our board of directors due to his experience as a business leader in the healthcare industry and his contacts and relationships.

David Lang is a director nominee . Mr. Lang is a private equity investor who specializes in healthcare services, healthcare technology and software/services sectors. He began his career as a financial analyst at Merrill Lynch, then moved to TA Associates as a software associate in 1990. Mr. Lang spent 25 years at TA Associates in various roles, including Managing Director in its healthcare team. At TA Associates, Mr. Lang led investments in numerous companies, including One Call Medical, TARGUSinfo, American Access Care, Alma Lasers, Intercontinental Exchange, National Imaging Associates, MQ Associates, Medsolutions/Evicore and Lawson Software. Mr. Lang is Chairman of the Board of Lahey Hospital and Medical Clinic, Director at Connected Home Care, American Endovascular, Alumni Ventures Group, Clearview Dermatology, Noble Rock Acquisition Corporation, Lexington Medical, Earthwatch Institute, and Community Action Partners. Mr. Lang graduated from Harvard College in 1989 and Harvard Business School in 1995. We believe Mr. Lang is well-qualified to serve as a member of our board of directors due to his experience in the healthcare industry and his contacts and relationships.

David H. Klein is a director nominee . Mr. Klein is a corporate director and advisor to companies in the healthcare industry. Mr. Klein was most recently the Chief Executive Officer of the Lifetime Healthcare companies (Lifetime), a multi-billion-dollar diversified healthcare company with health insurance and health care delivery operations. He currently serves as director of the not-for-profit publicly funded New York eHealth Collaborative, not-for-profit Massachusetts-based Commonwealth Care Alliance health plan, Landmark Health, Avalon Healthcare Solutions, Cogito, NextHealth Technologies, CTG, and Transparent Health Marketplace. From 2003 to 2012, Mr. Klein was the Chief Executive Officer of The Lifetime Healthcare Companies, a diversified healthcare company with health insurance and health care delivery operations (“Lifetime”). Mr. Klein had been a senior executive with Lifetime and its predecessor companies since 1986. Mr. Klein received his Bachelor of Science from Rensselaer Polytechnic Institute and his Master of Business Administration from the University of Chicago. We believe Mr. Klein is well-qualified to serve as a member of our board of directors due to his experience in the healthcare industry and his contacts and relationships.

Afsaneh Naimollah is a director nominee . Since October 2017, Ms. Naimollah has been an Executive-in-Residence at Plug & Play Tech Center (“PnP”), an early-stage venture capital and corporate innovation platform where she selectively mentors healthcare and technology companies on their business strategy. Since July 2016, Ms. Naimollah has been the managing partner of XEN Partners, a corporate advisory and investment banking firm focused on the healthcare industry. From October 2009 to June 2016, she was a partner and head of healthcare investment banking at Marlin & Associates, an investment banking and strategic advisory firm. From February 2000 to October 2009, Ms. Naimollah served as managing partner of Chela Capital Partners, an investment banking firm focused on healthcare and technology industries. From 1984 to January 2000, Ms. Naimollah worked at Barclays Capital’s U.S. Energy Group and later its U.S. Technologies Group, and assumed various leadership roles, including as Global Head of the latter group. From 2005 to 2010, Ms. Naimollah served on the board of ON2 Technologies, a video technology firm that was acquired by Google. Ms. Naimollah received her MBA in International Finance from University of Wisconsin, Madison and her BA in Economics and Philosophy from Milton College. We believe Ms. Naimollah is well-qualified to serve as a member of our board of directors due to her experience in the investment banking and healthcare industries and her contacts and relationships.

Our Advisors

Tom Cibotti will be an advisor to our board of directors . A member of our sponsor group, Mr. Cibotti is currently the Managing Partner and one of the founding members of Covington Associates, which he joined in 1993. With over 30 years of investment banking experience, Mr. Cibotti has advised on over 200 buy -side and sell-side transactions in the healthcare and healthcare IT industries, comprising in excess of $20 billion in transaction value. Mr. Cibotti was a key part of the Covington team involved in the $1.3 billion sale of Inverness Medical Technology to Johnson & Johnson and the $1.8 billion acquisition of Biosite, Inc. In addition to developing Covington’s strategic direction, Mr. Cibotti oversees Covington’s business development efforts as well as the transaction execution teams. Prior to Covington Associates, Mr. Cibotti was an Associate Director of Barclays de Zoete Wedd (“BZW”) from 1989 to 1993 where he focused principally in the areas of structured acquisition finance and private placements. Before joining BZW, Mr. Cibotti was an Associate at Chase Manhattan Bank. Mr. Cibotti holds a Bachelor of Science degree from Boston College in Finance and Economics and an MBA from NYU Stern School of Business.

Tim McMahon will be an advisor to our board of directors . A member of our sponsor group, Mr. McMahon joined Covington Associates as a Managing Director in 2005. He is a long-time investment banker experienced in the technology and healthcare sectors. He brings over 25 years of experience in investment banking for leading middle market and growth companies. Prior to joining Covington, Mr. McMahon was President and CEO of Adams Harkness Inc. During his tenure at Adams Harkness, he oversaw the expansion of the Investment Banking and Capital Markets business and helped the firm to develop top ranked practices in middle markets. Mr. McMahon has personally advised on over 100 client engagements. Mr. McMahon led the establishment of the Adams Harkness Wealth and Asset Management Divisions including its Venture Capital Fund. Mr. McMahon received a BS/BA from Boston University and an MBA from Babson College.

James Vandervelden will be an advisor to our board of directors . A member of our sponsor group, Mr. Vandervelden is Managing Partner and Co-Founder of Pleasant Bay Capital Partners (“PBCP”) and has over 25 years of private equity experience. In 2012, Mr. Vandervelden teamed up with Covington Associates to form PBCP, a private equity firm focused on working with family offices, high net worth individuals and institutional investors in the acquisition, growth, and recapitalization of lower-middle market companies. Prior to PBCP, Mr. Vandervelden was a Co-Founder and General Partner of Ticonderoga Capital Inc., a private equity firm that managed multiple dedicated investment funds focused on healthcare, technology, and technology enabled business services. Prior to Ticonderoga, Mr. Vandervelden worked at Dillon Read & Co.’s venture capital group making growth equity investments for its fund. He worked previously with TA Associates where he focused on management buyouts, recapitalizations, and minority growth capital investments of lower middle market technology and service-related businesses. Mr. Vandervelden received a B.A. in Economics and Organizational Behavior & Management, with Honors, from Brown University.